According to Fortune Business Insights, the global lung cancer screening market was valued at USD 3.28 billion in 2023. The market is projected to grow from USD 3.55 billion in 2024 to USD 7.10 billion by 2032, exhibiting a CAGR of 9.1% during the forecast period. In 2023, North America dominated the lung cancer screening market with a market share of 54.27%.